Aptargroup (ATR) Cash from Investing Activities (2009 - 2026)
Aptargroup (ATR) posted quarterly Cash from Investing Activities of -$56.8 million for Q2 2026, up 18.22% year-over-year from -$48.0 million in Q2 2025, and up 12.77% on a QoQ basis from -$65.1 million in Q1 2026.
Aptargroup (ATR) Cash from Investing Activities (2009 - 2026) Analysis & Trends
Aptargroup has reported Cash from Investing Activities for 18 years, with the latest figure at -$56.8 million in Q2 2026.
- Cash from Investing Activities for Q2 2026 came in at -$56.8 million, up 18.22% year-over-year; the trailing twelve-month figure through Jun 2026 was -$327.2 million (up 13.38% YoY), and the FY2025 annual result was -$331.4 million, up 16.46% from the prior year.
- Cash from Investing Activities rose to -$56.8 million in Q2 2026, from -$65.1 million in the prior quarter.
- Over five years, Cash from Investing Activities peaked at -$56.6 million in Q1 2025 and troughed at -$171.1 million in Q4 2024.
- A 5-year average of -$81.7 million and a median of -$75.1 million in 2023 frame the typical range for Cash from Investing Activities.
- The widest annual swing landed in 2022, when Cash from Investing Activities surged 59.64%; it then sank 100.96% in 2024.
- A 5-year view of Cash from Investing Activities shows it stood at -$73.2 million in 2022, then decreased by 16.23% to -$85.1 million in 2023, then tumbled by 100.96% to -$171.1 million in 2024, then jumped by 32.01% to -$116.3 million in 2025, then soared by 51.17% to -$56.8 million in 2026.
- Per Business Quant data, the three most recent Cash from Investing Activities figures were -$56.8 million in Q2 2026, -$65.1 million in Q1 2026, and -$116.3 million in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | -26.60 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | -241.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | -222.00 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | -383.65 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | -461.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | -43.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | -87.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | -90.00 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | -117.00 Mn |
| 10 | Aptargroup | 8.58 Bn | 8.38 Bn | 365.52 Mn | -56.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -56.79 Mn |
| Jun 30, 2026 | -56.79 Mn |
| Mar 31, 2026 | -65.10 Mn |
| Mar 31, 2026 | -65.10 Mn |
| Dec 31, 2025 | -116.31 Mn |
| Dec 31, 2025 | -116.31 Mn |
| Sep 30, 2025 | -89.05 Mn |
| Sep 30, 2025 | -89.05 Mn |
| Jun 30, 2025 | -69.44 Mn |
| Jun 30, 2025 | -69.44 Mn |
| Mar 31, 2025 | -56.63 Mn |
| Mar 31, 2025 | -56.63 Mn |
| Dec 31, 2024 | -171.07 Mn |
| Dec 31, 2024 | -171.07 Mn |
| Sep 30, 2024 | -80.67 Mn |
| Sep 30, 2024 | -80.67 Mn |
| Jun 30, 2024 | -68.41 Mn |
| Jun 30, 2024 | -68.41 Mn |
| Mar 31, 2024 | -76.57 Mn |
| Mar 31, 2024 | -76.57 Mn |